Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis : New Insights From Biomarker Studies
Reyes-Leiva, David; Dols Icardo, Oriol; Sirisi, Sonia; Cortés-Vicente, Elena; Turon-Sans, Janina; de Luna Salva, Noemí; Blesa, Rafael; Belbin, Olivia; Montal, Victor; Alcolea, Daniel; Fortea, Juan; Lleó, Alberto; Rojas-Garcia, Ricard; Illán-Gala, Ignacio; Universitat Autònoma de Barcelona
Altres ajuts:Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innovació en Salut (SLT002/16/00408 to AL), Fundació La Marató de TV3 (044412 to RB and 201437.10 to RR-G).
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) lie at opposing ends of a clinical, genetic, and neuropathological continuum. In the last decade, it has become clear that cognitive and behavioral changes in patients with ALS are more frequent than previously recognized. Significantly, these non-motor features can impact the diagnosis, prognosis, and management of ALS. Partially overlapping neuropathological staging systems have been proposed to describe the distribution of TAR DNA-binding protein 43 (TDP-43) aggregates outside the corticospinal tract. However, the relationship between TDP-43 inclusions and neurodegeneration is not absolute and other pathophysiological processes, such as neuroinflammation (with a prominent role of microglia), cortical hyperexcitability, and synaptic dysfunction also play a central role in ALS pathophysiology. In the last decade, imaging and biofluid biomarker studies have revealed important insights into the pathophysiological underpinnings of extra-motor neurodegeneration in the ALS-FTLD continuum. In this review, we first summarize the clinical and pathophysiological correlates of extra-motor neurodegeneration in ALS. Next, we discuss the diagnostic and prognostic value of biomarkers in ALS and their potential to characterize extra-motor neurodegeneration. Finally, we debate about how biomarkers could improve the diagnosis and classification of ALS. Emerging imaging biomarkers of extra-motor neurodegeneration that enable the monitoring of disease progression are particularly promising. In addition, a growing arsenal of biofluid biomarkers linked to neurodegeneration and neuroinflammation are improving the diagnostic accuracy and identification of patients with a faster progression rate. The development and validation of biomarkers that detect the pathological aggregates of TDP-43 in vivo are notably expected to further elucidate the pathophysiological underpinnings of extra-motor neurodegeneration in ALS. Novel biomarkers tracking the different aspects of ALS pathophysiology are paving the way to precision medicine approaches in the ALS-FTLD continuum. These are essential steps to improve the diagnosis and staging of ALS and the design of clinical trials testing novel disease-modifying treatments.
-Amyotrophic lateral sclerosis (ALS)
-Neuroimage
-Cerebrospinal fluid (CSF)
-Biomarker (BM)
-Neuropathology
-TDP-43 = TAR DNA-binding protein 43
-Frontotemporal lobar degeneration
-Frontotemporal dementia (FTD)
open access
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
https://creativecommons.org/licenses/by/4.0/
Article de revisió
         
https://ddd.uab.cat/record/252268

Show full item record

Related documents

Other documents of the same author

Alcolea, Daniel; Clarimón, Jordi; Carmona Iragui, María; Illán-Gala, Ignacio; Morenas-Rodríguez, Estrella; Barroeta, Isabel; Ribosa-Nogué, Roser; Sala, Isabel; Sánchez-Saudinós, M. Belén; Videla Toro, Laura; Subirana, Andrea; Benejam, Bessy; Valldeneu, Silvia; Fernández, Susana; Estellés, Teresa; Altuna-Azkargorta, Miren; Santos-Santos, Miguel; García-Losada, Lídia; Bejanin, Alexandre; Pegueroles, Jordi; Montal, Victor; Vilaplana, Eduard; Belbin, Olivia; Dols Icardo, Oriol; Sirisi, Sònia; Querol-Vilaseca, Marta; Cervera Carles, Laura; Muñoz, Laia; Núñez-Llaves, Raúl; Torres, Soraya; Camacho, M. Valle; Carrió, Ignasi; Giménez, Sandra; Delaby, Constance; Rojas-Garcia, Ricard; Turon-Sans, Janina; Pagonabarraga Mora, Javier; Jiménez, Amanda; Blesa, Rafael; Fortea, Juan; Lleó, Alberto; Universitat Autònoma de Barcelona
Dols Icardo, Oriol; Montal, Victor; Sirisi, Sònia; López-Pernas, Gema; Cervera Carles, Laura; Querol-Vilaseca, Marta; Muñoz, Laia; Belbin, Olivia; Alcolea, Daniel; Molina-Porcel, Laura; Pegueroles, Jordi; Turón-Sans, Janina; Blesa, Rafael; Lleó, Alberto; Fortea, Juan; Rojas-Garcia, Ricard; Clarimón, Jordi; Universitat Autònoma de Barcelona
Jimenez, Amanda; Pegueroles, Jordi; Carmona Iragui, María; Vilaplana, Eduard; Montal, Victor; Alcolea, Daniel; Videla Toro, Laura; Illán-Gala, Ignacio; Pané, Adriana; Casajoana, Anna; Belbin, Olivia; Clarimón, Jordi; Moizé, Violeta; Vidal, Josep; Lleó, Alberto; Fortea, Juan; Blesa, Rafael; Universitat Autònoma de Barcelona
Delaby, Constance; Alcolea, Daniel; Carmona Iragui, María; Illán-Gala, Ignacio; Morenas Rodríguez, Estrella; Barroeta, Isabel; Altuna-Azkargorta, Miren; Estellés, T.; Santos-Santos, M.; Turon-Sans, J.; Muñoz, L.; Ribosa-Nogué, Roser; Sala-Matavera, I.; Sánchez-Saudinós, María Belén; Subirana, A.; Videla Toro, Laura; Benejam, Bessy; Sirisi Dolcet, Sonia; Lehmann, S.; Belbin, Olivia; Clarimón, Jordi; Blesa, Rafael; Pagonabarraga Mora, Javier; Rojas-Garcia, Ricard; Fortea, Juan; Lleó, Alberto; Universitat Autònoma de Barcelona
Cervantes González, Alba; Irwin, David J.; Alcolea, Daniel; McMillan, Corey T.; Chen-Plotkin, Alice; Wolk, David; Sirisi Dolcet, Sonia; Dols Icardo, Oriol; Querol-Vilaseca, Marta; Illán-Gala, Ignacio; Santos-Santos, Miguel Angel; Fortea, Juan; Lee, Edward B.; Trojanowski, John Q.; Grossman, Murray; Lleó, Alberto; Belbin, Olivia; Universitat Autònoma de Barcelona
 

Coordination

 

Supporters